Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
Clinical trial NCT04830215 · COMPLETED
Trial details
- NCT number
- NCT04830215
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-05-27
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.